Topics:

HIV AIDS

Can Statins Prevent CVD in Patients with HIV?

Statins effectively lower levels of various pro-inflammatory markers of immune activation. So can statin therapy prevent CVD events in HIV-infected persons?

HIV AIDS

The antiviral future holds great promise for people living with HIV: better-tolerated, less toxic, drugs are about to come to market, and we are about to see the introduction of drugs from 1 or 2 new classes.

Here is compelling reason why every MD needs to test his or her patients for HCV, and get them into therapy as soon as possible.

Here’s a look at how emergency room experiences affect linkage to care and retention in care among patients with HIV.

Here: an update on progress and challenges in HIV eradication, and a focus on the efforts of the President’s Emergency Plan for AIDS Relief.

Is pre-exposure prophylaxis an effective means of reducing the number of new HIV infections?

Do we, in resource-rich countries, have the will and the resources to spend on HIV or HCV eradication? We have the tools (medications), but the goal of eradicating both infections seems as elusive as ever.

HIV-infected men appear to be using testosterone replacement without adequate baseline evaluation and establishment of recommended indications.

Pages

Subscribe to HIV AIDS on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.